Mycobacterium tuberculosis Infection: Control & Treatment
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Public Health Microbiology".
Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 21676
Special Issue Editor
Interests: mycobacteria dormancy and resuscitation; TB drug discovery; small non-coding RNA; transcriptomics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Tuberculosis (TB) is the leading cause of death from a single infectious agent that claims the lives of more than 1.5 million people per year, and a growing number of multidrug-resistant TB strains constitute a major health threat. Moreover, Mycobacterium tuberculosis has developed a plethora of molecular mechanisms providing successful escape from host immunity by expressing specific factors and regulators which contribute to the progression of the disease. An additional challenge concerns latent TB—about 1.7 billion people are latently infected with M. tuberculosis with a lifetime risk of developing the active disease. Thus, improvement of vaccines and diagnostic testing, and continued drug discovery for active and latent TB, is critical to address the global health need, especially in the era of the COVID-19 pandemic when the burden on the healthcare system is very high.
We look forward to receiving your contributions to this Special Issue which concern any aspects of arising challenges and future perspectives on TB control and treatment.
Dr. Elena G. Salina
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.